DOCSLIB.ORG

Growth Curves for Laron Syndrome Arch Dis Child: First Published As 10.1136/Adc.68.6.768 on 1 June 1993

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Growth Curves for Laron Syndrome Arch Dis Child: First Published As 10.1136/Adc.68.6.768 on 1 June 1993 768 Archives ofDisease in Childhood 1993; 68: 768-770 Growth curves for Laron syndrome Arch Dis Child: first published as 10.1136/adc.68.6.768 on 1 June 1993. Downloaded from Z Laron, P Lilos, B Klinger Abstract hormone and very low concentrations of insulin- Growth curves for children with Laron like growth factor-I (IGF-I).4 The pathogenesis syndrome were constructed on the basis of of this syndrome has been found to reside in the repeated measurements made throughout growth hormone receptors' and is due to infancy, childhood, and puberty in 24 (10 boys, molecular defects mostly in the extracellular 14 girls) of the 41 patients with this syndrome domain of the receptor gene.8 This defect leads investigated in our clinic. Growth retardation to an inability of the liver to synthesise the was already noted at birth, the birth length growth hormone dependent IGF-I resulting in a ranging from 42 to 46 cm in the 12/20 available marked impairment of body and organ growth. measurements. The postnatal growth curves The extreme short stature of these patients is deviated sharply from the normal from infancy very severe and starts in utero, and their final on. Both sexes showed no clear pubertal spurt. heights are very low. Their upper to lower body Girls completed their growth between the age proportions are more than 2 SD above the of 16-19 years to a final mean (SD) height of normal mean2 denoting a lag in growth of the 119 (8.5) cm whereas the boys continued grow- lower limbs compared with the body. ing beyond the age of20 years, achieving a final We followed up a group ofpatients with Laron height of 124 (8.5) cm. At all ages the upper to syndrome from infancy to final height and we lower body segment ratio was more than 2 SD present their growth curves, growth velocity above the normal mean. These growth curves curves, and the final heights of both sexes. constitute a model not only for primary, These curves constitute a model for untreated hereditary insulin-like growth factor-I (IGF-I) hereditary/congenital deficiency of growth deficiency (Laron syndrome) but also for hormone releasing hormone, growth hormone, untreated secondary IGF-I deficiencies such or IGF-I. as growth hormone gene deletion and idio- pathic congenital isolated growth hormone deficiency. They should also be useful in the Patients and methods follow up of children with Laron syndrome Out of 41 patients with Laron syndrome who treated with biosynthetic recombinant IGF-I. were diagnosed and examined at our clinic (30 of (Arch Dis Child 1993; 68: 768-770) Jewish and 11 of Arab origin),9 24 were followed up closely from infancy into adulthood, almost http://adc.bmj.com/ all being measured once or twice a year. At each Laron syndrome is a recessively inherited visit they underwent a complete physical exami- disease' 2 that is clinically indistinguishable from nation, including anthropometric measurements growth hormone deficiency.' It is characterised (length and height), performed by the same two by high concentrations of circulating growth nurses using Harpenden stadiometers. For sit- on September 25, 2021 by guest. Protected copyright. Institute ofPediatric and Adolescent Endocrinology, Children's Medical CD) 0i Center, Beilinson - Sackler -c ._ Campus, Faculty a) ofMedicine I I Z Laron B Klinger Statistical Laboratory, School of Mathematical Sciences, Tel Aviv University, Israel P Lilos Correspondence to: Professor Z Laron, Institute of Pediatric and Adolescent Endocrinology, Children's Medical Center, Beilinson Age Age (years) Campus, Petah Tikva 49100, (years) Israel. Figure I Growth curvefor height in girls with Laron Figure 2 Growth curvefor height in boys with Laron Accepted 21 January 1993 syndromefrom birth to 20years. syndromefrom birth to 20years. Growth curvesforLaron syndrome 769 30 i| Girls 0 2 10| Girls t 200L a) 1-901 Arch Dis Child: first published as 10.1136/adc.68.6.768 on 1 June 1993. Downloaded from 25 E, 180 D 170 I -I v 11606 co 0 20 E 140s1 0 01-30 *: * **. : * 2SD 4 1 SD 220 Mean 15 CD 1.10 . Figur0.ooS.peOlwrbd emn aisi Igrswl . 0 S 1234567~8'9 1'11'3 15 1'7 10 tt~~~~~~~~ 10 12 14 16 18 I Age (years) FigureS5 Upper to lower body segment ratios in I11 girls with 5 Laron syndrome plotted on Arad/Laron charts.'0 - Figure 3 Growth velocity un F _,I . .. curve in girls with Laron 5 10 15 20 and height curves were smoothed using the syndromefrom birth to 20 'Lowess' method.'2 The final height was estab- years. Age (years) lished when the subjects grew less than 1 cm during one year. ting height an anthropometer was used, the Results length of the lower segment being calculated by Twenty newborn infants had birth length subtracting sitting height from total height. measured9 and in 12 it ranged from 42 to 46 cm They were compared with charts designed for and was 2 SD or more below the normal length healthy Israeli children." The 24 patients (10 for sex and ethnic origin.'3 In eight the birth boys, 14 girls) were found to have sufficient length was within normal limits. Figures 1 and 2 measurements to allow their inclusion in the represent the smoothed height growth curves as calculations ofgrowth charts. mean (2 SD) for girls and boys with Laron At first the growth increments over periods of syndrome. From the two charts it is seen that the 1-3 years were calculated for each sex separately. spread ofthe mean (2 SD) is wider in boys than in These increments enabled us to plot the growth girls. The girls reached their final height between velocity curve. ages 16-19 years whereas the boys continued to http://adc.bmj.com/ The height curves were constructed using the grow beyond age 20. The mean (SD) final height Tanner-Gupta method" as follows: the mean of the girls was 119-5 (8-5) cm and that of the height was calculated for boys at age 10 and for boys (reached around age 24 years and not shown girls at age 8 years. From these points the mean on the graphs) was 124- 1 (8-5) cm. Figures 3 and calculated yearly growth increments were added 4 illustrate the growth velocity curves ofthe girls or subtracted going backwards to birth (age 0) or and boys with Laron syndrome. It is evident that to 20. Both the forward up age growth velocity both sexes lack the typical pubertal growth on September 25, 2021 by guest. Protected copyright. spurt. The mean age at onset of puberty in girls was 10-7 (0-7) years and in boys 15-6 (2-6) years. Figures 5 and 6 show the upper to lower body segment ratio. 30 ' Boys 25 I .o 2-10 . Boys -C II 2-00 a) c 190 20 Eco E 1.80 CD)m 170 * clD 0 > 160 * 0 15 - S 0a0 0. 15000 10 1-0. I 0 09 OL 1 23578 1 3151 5 * . 12 3 4 5 6 7 8 9 11 13 1 5 17 10 12 14 16 18 Figure 4 Growth velocity uII _- -_---4--- Age (years) curve in boys with Laron 0 5 10 15 20 syndromefrom birth to 20 Figure 6 Upper to lower body segment ratios in 10 boys with years. Age (years) Laron syndrome plotted on Arad/Laron charts. '0 770 Laron, Lilos, Klinger Discussion deletion type IA patients25 with biosynthetic The use of a reference growth chart is routine IGF-I. in nowadays any paediatric clinic. Height and Arch Dis Child: first published as 10.1136/adc.68.6.768 on 1 June 1993. Downloaded from The authors wish to acknowledge the criticism and advice of growth are plotted on one of the several growth Professor J M Tanner in the preparation ofthis article. charts developed for normal children based on We also thank Dr M Lapidot and Mrs 0 Gordon for help at various stages of this study, and special thanks are due to the Tanner-Whitehouse charts.'4 For children Ms Dahlia Peled, RN, without whose exact measurements with certain diseases characterised by marked throughout the years this study would not have been possible. Z Laron is Incumbent ofthe Irene and Nicholas Marsh Chair of growth retardation and a typical growth pattern, Endocrinology and Juvenile Diabetes, Tel Aviv University. special growth charts have been established,' thus there is a growth curve for achondroplasia,'6 1 Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary for girls with Turner's and for dwarfism with high serum concentration of growth syndrome,'7 hormone. A new inborn error of metabolism? IsrJ Med Sci Noonan's syndrome.'8 1966; 2: 152-5. Children with Laron at a 2 Laron Z. Laron type dwarfism (hereditary somatomedin syndrome'2 grow deficiency): a review. In: Frick P, von Harnack GA, subnormal rate because of their inability to Kochseik K, Martini GA, Prader A, eds. Advances in internal which is caused medicine and pediatrics. Berlin-Heidelberg: Springer Verlag, generate endogenous IGF-I,4 by 1984: 117-50. a molecular defect in the growth hormone 3 Laron Z. Deficiencies of growth hormone and somatomedins and this results in a hormone in man. In: Cohen MP, Foa PP, eds. Special topics in receptors,5 growth endocrinology andmetabolism. Vol 5. New York: Alan R Liss, resistant state. These patients present a uniform 1983: 149-99. type of growth retardation. The we 4 Laron Z, Pertzelan A, Karp M, Kowadlo-Silbergeld A, opportunity Daughaday WH. Administration of growth hormone to had to follow up a large group of patients patients with familial dwarfism with high plasma immuno- throughout and childhood into adult- reactive growth hormone.
Load more

Recommended publications
  • Repercussions of Inborn Errors of Immunity on Growth☆ Jornal De Pediatria, Vol
    Jornal de Pediatria ISSN: 0021-7557 ISSN: 1678-4782 Sociedade Brasileira de Pediatria Goudouris, Ekaterini Simões; Segundo, Gesmar Rodrigues Silva; Poli, Cecilia Repercussions of inborn errors of immunity on growth☆ Jornal de Pediatria, vol. 95, no. 1, Suppl., 2019, pp. S49-S58 Sociedade Brasileira de Pediatria DOI: https://doi.org/10.1016/j.jped.2018.11.006 Available in: https://www.redalyc.org/articulo.oa?id=399759353007 How to cite Complete issue Scientific Information System Redalyc More information about this article Network of Scientific Journals from Latin America and the Caribbean, Spain and Journal's webpage in redalyc.org Portugal Project academic non-profit, developed under the open access initiative J Pediatr (Rio J). 2019;95(S1):S49---S58 www.jped.com.br REVIEW ARTICLE ଝ Repercussions of inborn errors of immunity on growth a,b,∗ c,d e Ekaterini Simões Goudouris , Gesmar Rodrigues Silva Segundo , Cecilia Poli a Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Departamento de Pediatria, Rio de Janeiro, RJ, Brazil b Universidade Federal do Rio de Janeiro (UFRJ), Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Curso de Especializac¸ão em Alergia e Imunologia Clínica, Rio de Janeiro, RJ, Brazil c Universidade Federal de Uberlândia (UFU), Faculdade de Medicina, Departamento de Pediatria, Uberlândia, MG, Brazil d Universidade Federal de Uberlândia (UFU), Hospital das Clínicas, Programa de Residência Médica em Alergia e Imunologia Pediátrica, Uberlândia, MG, Brazil e Universidad del Desarrollo,
    [Show full text]
  • Dwarfism Awareness
    LPA Mission Statement LPA is dedicated to improving the quality of life for people with dwarfism throughout their lives, while celebrating with great pride little people’s contribution to social diversity. LPA strives to bring solutions and global For More Information awareness to the prominent issues affecting individuals of Contact LPA short stature and their families. Toll Free…(888) LPA-2001 Direct....(714) 368-3689 Fax…..(707) 721-1896 Dwarfism Check out our website at Awareness www.lpaonline.org A Community Outreach Program 617 Broadway #518 Sponsored by Little People of America Sonoma, CA 95476 LPA is a non-profit tax exempt 501(c)3 organization funded by individual donations. Contact LPA to help. Dwarfism - Facts and Fiction Mythbusters Terminology Bodies come in all shapes and sizes. There are about 400 People with dwarfism are not magical; they do not fly, nor are Preferred terminology is a personal decision, but different types of dwarfism. Each type of dwarfism is they leprechauns, elves, fairies or any other mythological commonly accepted terms are - short stature, different than the other. Many types of dwarfism have creature. They are people - people whose bones happen to dwarfism, little person, dwarf. And we say some medical complications but most people have an grow differently than yours. That is all. "average-height" instead of "normal height". average lifespan, being productive members of society. People with dwarfism do not all know each People with dwarfism are different, yes, but not Eighty percent of people with dwarfism have average- other or look alike, nor are there towns "abnormal". height parents and siblings.
    [Show full text]
  • Prevalence and Incidence of Rare Diseases: Bibliographic Data
    Number 1 | January 2019 Prevalence and incidence of rare diseases: Bibliographic data Prevalence, incidence or number of published cases listed by diseases (in alphabetical order) www.orpha.net www.orphadata.org If a range of national data is available, the average is Methodology calculated to estimate the worldwide or European prevalence or incidence. When a range of data sources is available, the most Orphanet carries out a systematic survey of literature in recent data source that meets a certain number of quality order to estimate the prevalence and incidence of rare criteria is favoured (registries, meta-analyses, diseases. This study aims to collect new data regarding population-based studies, large cohorts studies). point prevalence, birth prevalence and incidence, and to update already published data according to new For congenital diseases, the prevalence is estimated, so scientific studies or other available data. that: Prevalence = birth prevalence x (patient life This data is presented in the following reports published expectancy/general population life expectancy). biannually: When only incidence data is documented, the prevalence is estimated when possible, so that : • Prevalence, incidence or number of published cases listed by diseases (in alphabetical order); Prevalence = incidence x disease mean duration. • Diseases listed by decreasing prevalence, incidence When neither prevalence nor incidence data is available, or number of published cases; which is the case for very rare diseases, the number of cases or families documented in the medical literature is Data collection provided. A number of different sources are used : Limitations of the study • Registries (RARECARE, EUROCAT, etc) ; The prevalence and incidence data presented in this report are only estimations and cannot be considered to • National/international health institutes and agencies be absolutely correct.
    [Show full text]
  • MECHANISMS in ENDOCRINOLOGY: Novel Genetic Causes of Short Stature
    J M Wit and others Genetics of short stature 174:4 R145–R173 Review MECHANISMS IN ENDOCRINOLOGY Novel genetic causes of short stature 1 1 2 2 Jan M Wit , Wilma Oostdijk , Monique Losekoot , Hermine A van Duyvenvoorde , Correspondence Claudia A L Ruivenkamp2 and Sarina G Kant2 should be addressed to J M Wit Departments of 1Paediatrics and 2Clinical Genetics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Email The Netherlands [email protected] Abstract The fast technological development, particularly single nucleotide polymorphism array, array-comparative genomic hybridization, and whole exome sequencing, has led to the discovery of many novel genetic causes of growth failure. In this review we discuss a selection of these, according to a diagnostic classification centred on the epiphyseal growth plate. We successively discuss disorders in hormone signalling, paracrine factors, matrix molecules, intracellular pathways, and fundamental cellular processes, followed by chromosomal aberrations including copy number variants (CNVs) and imprinting disorders associated with short stature. Many novel causes of GH deficiency (GHD) as part of combined pituitary hormone deficiency have been uncovered. The most frequent genetic causes of isolated GHD are GH1 and GHRHR defects, but several novel causes have recently been found, such as GHSR, RNPC3, and IFT172 mutations. Besides well-defined causes of GH insensitivity (GHR, STAT5B, IGFALS, IGF1 defects), disorders of NFkB signalling, STAT3 and IGF2 have recently been discovered. Heterozygous IGF1R defects are a relatively frequent cause of prenatal and postnatal growth retardation. TRHA mutations cause a syndromic form of short stature with elevated T3/T4 ratio. Disorders of signalling of various paracrine factors (FGFs, BMPs, WNTs, PTHrP/IHH, and CNP/NPR2) or genetic defects affecting cartilage extracellular matrix usually cause disproportionate short stature.
    [Show full text]
  • Update on New GH-IGF Axis Genetic Defects
    review Update on new GH-IGF axis genetic defects Gabriela A. Vasques1,2 1 Unidade de Endocrinologia https://orcid.org/0000-0002-6455-8682 Genética, Laboratório de Endocrinologia Celular e Nathalia L. M. Andrade1,2 https://orcid.org/0000-0002-1628-7881 Molecular (LIM25), Hospital das Clínicas, Faculdade de Fernanda A. Correa2 Medicina, Universidade de São https://orcid.org/0000-0003-2107-9494 Paulo, São Paulo, SP, Brasil 2 Alexander A. L. Jorge1,2 Unidade de Endocrinologia do https://orcid.org/0000-0003-2567-7360 Desenvolvimento, Laboratório de Hormônios e Genética Molecular (LIM42), Hospital das Clínicas, Faculdade de ABSTRACT Medicina, Universidade de São The somatotropic axis is the main hormonal regulator of growth. Growth hormone (GH), also known Paulo, São Paulo, SP, Brasil as somatotropin, and insulin-like growth factor 1 (IGF-1) are the key components of the somatotropic axis. This axis has been studied for a long time and the knowledge of how some molecules could Correspondence to: promote or impair hormones production and action has been growing over the last decade. The Alexander A. L. Jorge Laboratório de Endocrinologia enhancement of large-scale sequencing techniques has expanded the spectrum of known genes and Celular e Molecular (LIM25), several other candidate genes that could affect the GH-IGF1-bone pathway. To date, defects in more Faculdade de Medicina, than forty genes were associated with an impairment of the somatotropic axis. These defects can Universidade de São Paulo Av. Dr. Arnaldo, 455, affect from the secretion of GH to the bioavailability and action of IGF-1. Affected patients present a 5º andar, sala 5.340 large heterogeneous group of conditions associated with growth retardation.
    [Show full text]
  • Genetic Disorder
    Genetic disorder Single gene disorder Prevalence of some single gene disorders[citation needed] A single gene disorder is the result of a single mutated gene. Disorder Prevalence (approximate) There are estimated to be over 4000 human diseases caused Autosomal dominant by single gene defects. Single gene disorders can be passed Familial hypercholesterolemia 1 in 500 on to subsequent generations in several ways. Genomic Polycystic kidney disease 1 in 1250 imprinting and uniparental disomy, however, may affect Hereditary spherocytosis 1 in 5,000 inheritance patterns. The divisions between recessive [2] Marfan syndrome 1 in 4,000 and dominant types are not "hard and fast" although the [3] Huntington disease 1 in 15,000 divisions between autosomal and X-linked types are (since Autosomal recessive the latter types are distinguished purely based on 1 in 625 the chromosomal location of Sickle cell anemia the gene). For example, (African Americans) achondroplasia is typically 1 in 2,000 considered a dominant Cystic fibrosis disorder, but children with two (Caucasians) genes for achondroplasia have a severe skeletal disorder that 1 in 3,000 Tay-Sachs disease achondroplasics could be (American Jews) viewed as carriers of. Sickle- cell anemia is also considered a Phenylketonuria 1 in 12,000 recessive condition, but heterozygous carriers have Mucopolysaccharidoses 1 in 25,000 increased immunity to malaria in early childhood, which could Glycogen storage diseases 1 in 50,000 be described as a related [citation needed] dominant condition. Galactosemia
    [Show full text]
  • Laron Syndrome
    Laron syndrome Description Laron syndrome is a rare form of short stature that results from the body's inability to use growth hormone, a substance produced by the brain's pituitary gland that helps promote growth. Affected individuals are close to normal size at birth, but they experience slow growth from early childhood that results in very short stature. If the condition is not treated, adult males typically reach a maximum height of about 4.5 feet; adult females may be just over 4 feet tall. Other features of untreated Laron syndrome include reduced muscle strength and endurance, low blood sugar levels (hypoglycemia) in infancy, small genitals and delayed puberty, hair that is thin and fragile, and dental abnormalities. Many affected individuals have a distinctive facial appearance, including a protruding forehead, a sunken bridge of the nose (saddle nose), and a blue tint to the whites of the eyes (blue sclerae). Affected individuals have short limbs compared to the size of their torso, as well as small hands and feet. Adults with this condition tend to develop obesity. However, the signs and symptoms of Laron syndrome vary, even among affected members of the same family. Studies suggest that people with Laron syndrome have a significantly reduced risk of cancer and type 2 diabetes. Affected individuals appear to develop these common diseases much less frequently than their unaffected relatives, despite having obesity (a risk factor for both cancer and type 2 diabetes). However, people with Laron syndrome do not seem to have an increased lifespan compared with their unaffected relatives. Frequency Laron syndrome is a rare disorder.
    [Show full text]
  • Fibrochondrogenesis
    Fibrochondrogenesis Description Fibrochondrogenesis is a very severe disorder of bone growth. Affected infants have a very narrow chest, which prevents the lungs from developing normally. Most infants with this condition are stillborn or die shortly after birth from respiratory failure. However, some affected individuals have lived into childhood. Fibrochondrogenesis is characterized by short stature (dwarfism) and other skeletal abnormalities. Affected individuals have shortened long bones in the arms and legs that are unusually wide at the ends (described as dumbbell-shaped). People with this condition also have a narrow chest with short, wide ribs and a round and prominent abdomen. The bones of the spine (vertebrae) are flattened (platyspondyly) and have a characteristic pinched or pear shape that is noticeable on x-rays. Other skeletal abnormalities associated with fibrochondrogenesis include abnormal curvature of the spine and underdeveloped hip (pelvic) bones. People with fibrochondrogenesis also have distinctive facial features. These include prominent eyes, low-set ears, a small mouth with a long upper lip, and a small chin ( micrognathia). Affected individuals have a relatively flat-appearing midface, particularly a small nose with a flat nasal bridge and nostrils that open to the front rather than downward (anteverted nares). Vision problems, including severe nearsightedness (high myopia) and clouding of the lens of the eye (cataract), are common in those who survive infancy. Most affected individuals also have sensorineural hearing loss, which is caused by abnormalities of the inner ear. Frequency Fibrochondrogenesis appears to be a rare disorder. About 20 affected individuals have been described in the medical literature. Causes Fibrochondrogenesis can result from mutations in the COL11A1 or COL11A2 gene.
    [Show full text]
  • Blueprint Genetics Comprehensive Growth Disorders / Skeletal
    Comprehensive Growth Disorders / Skeletal Dysplasias and Disorders Panel Test code: MA4301 Is a 374 gene panel that includes assessment of non-coding variants. This panel covers the majority of the genes listed in the Nosology 2015 (PMID: 26394607) and all genes in our Malformation category that cause growth retardation, short stature or skeletal dysplasia and is therefore a powerful diagnostic tool. It is ideal for patients suspected to have a syndromic or an isolated growth disorder or a skeletal dysplasia. About Comprehensive Growth Disorders / Skeletal Dysplasias and Disorders This panel covers a broad spectrum of diseases associated with growth retardation, short stature or skeletal dysplasia. Many of these conditions have overlapping features which can make clinical diagnosis a challenge. Genetic diagnostics is therefore the most efficient way to subtype the diseases and enable individualized treatment and management decisions. Moreover, detection of causative mutations establishes the mode of inheritance in the family which is essential for informed genetic counseling. For additional information regarding the conditions tested on this panel, please refer to the National Organization for Rare Disorders and / or GeneReviews. Availability 4 weeks Gene Set Description Genes in the Comprehensive Growth Disorders / Skeletal Dysplasias and Disorders Panel and their clinical significance Gene Associated phenotypes Inheritance ClinVar HGMD ACAN# Spondyloepimetaphyseal dysplasia, aggrecan type, AD/AR 20 56 Spondyloepiphyseal dysplasia, Kimberley
    [Show full text]
  • Subbarao K Skeletal Dysplasia (Non - Sclerosing Dysplasias – Part II)
    REVIEW ARTICLE Skeletal Dysplasia (Non - Sclerosing dysplasias – Part II) Subbarao K Padmasri Awardee Prof. Dr. Kakarla Subbarao, Hyderabad, India Introduction Out of 70 dwarfism syndromes, the most In continuation with Sclerosing Dysplasias common form of dwarfism is (Part I), non sclerosing dysplasias constitute achondroplasia. It is a proportionate a major group of skeletal lesions including dwarfism and is rhizomelic in 70% of the dwarfism syndromes. The following list patients. It is autosomal dominant. There is includes most of the common dysplasias rhizomelic type of short limbs with increased either involving epiphysis, metaphysis, spinal curvature. Skull abnormalities are also diaphysis or epimetaphysis. These include noted. The radiographic features are multiple epiphyseal dysplasia, spondylo- mentioned in Table I. epiphyseal dysplasia, metaphyseal dysplasia, spondylometaphyseal dysplasia and Table I: Achondroplasia- Radiographic epimetaphyseal dysplasia (Hindigodu features Syndrome). These are included in dwarfism Large skull with prominent frontal syndromes. bones and a narrow base. The interpedicular distance decreases Dwarfism indicates a short person in stature caudally in lumbar region but with due to genetic or acquired causes. It is normal vertebral height. defined as an adult height of less than Posterior scalloping 147 cm (4 feet 10 inches). The pelvis is square with small sciatic notches and the inlet The average height of Indians is men- 5ft 3 configuration with classical ½ inches and women–5 ft 0 inches much less champagne glass appearance than average American or Chinese people. Trident hands Delayed appearance of carpal bones Dwarfism syndromes consist of 200 distinct Dumb bell shaped limb bones medical entities. In Proportionate Dwarfism, the body appears normally proportioned, but is unusually small.
    [Show full text]
  • Test Requisition Form (Dna & Genetic Tests)
    TEST REQUISITION FORM (DNA & GENETIC TESTS) INCLUDE THE FIRST 3 PAGES OF THIS FORM WITH SPECIMEN. Before sending specimens, please contact us for pre-authorization procedures. Samples received without billing pre-authorization cannot be processed. REPORTING INFORMATION ADDITIONAL REPORTS Ordering Physician or Genetic Counselor Copy of report should be sent to Name: Name: Email: Email: Institution: Fax: ( ) Address: City, State, Zip: Name: Phone: ( ) Email: Fax: ( ) Fax: ( ) PATIENT INFORMATION Patient's Last Name, First Name, MI Birthdate (mm/dd/yyyy) Gender M F Indication or reason for testing (check all that apply) Diagnosis Asymptomatic family member Confirm recorded mutation: High risk population (state Ancestry or Ethnic background below) Prenatal screening Ongoing pregnancy Other: Ancestry or Ethnic Background (check all that apply) Patient's country of origin Ethnic Background Hispanic Jewish Asian Middle-East Americas Europe Africa Australia Hospital or Clinic Patient ID Specimen ID Diagnosis (ICD9 codes) SPECIMEN INFORMATION (REQUIRED) Specimen Date/Time Collected Collected by (initial) Specimen Type (If other, please contact us before shipping) / / _____:_____ AM/PM Buccal Blood Other: Specimen may be submitted as whole blood or buccal epithelial cells (2 swabs / patient). Transport at room temperature. For other specimens and more details, see page labeled "Specimen Requirements". TESTS REQUESTED (Ask us to customize the requisition form for your practice) Test No. Test Name 1. Stat 2. Stat 3. Stat Test Names are found on the list at the end of this form. The tests will be performed in the order listed. Turnaround times are usually less than 5 weeks following receipt of specimen. Sequential panels of several large genes will take longer depending on which gene positive results are found.
    [Show full text]
  • Fibrochondrogenesis, an Antenatal and Postnatal Correlation
    Editor-in-Chief: Vikram S. Dogra, MD OPEN ACCESS Department of Imaging Sciences, University of Rochester Medical Center, Rochester, USA HTML format Journal of Clinical Imaging Science For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.asp www.clinicalimagingscience.org CASE REPORT Fibrochondrogenesis, an Antenatal and Postnatal Correlation Nischal G. Kundaragi, Kishor Taori, Chetan Jathar, Amit Disawal Department of Radiodiagnosis, Government Medical College, Nagpur, India Address for correspondence: Dr. Nischal G. Kundaragi, ABSTRACT Consultant, Government Medical College, Nagpur and SRM University Fibrochondrogenesis is a rare, neonatally lethal osteochondrodysplasia, with autosomal Medical College, Kanchipurum, recessive inheritance. It differs from other lethal dwarfisms in that it leads to broad, Tamil Nadu, India. long-bone metaphyses (dumb-bell shaped) and pear-shaped vertebral bodies. E-mail: [email protected] We report a case of fibrochondrogenesis with severe pear-shaped platyspondyly, suspected antenatally, and give a comprehensive pictorial review of the antenatal ultrasound and postnatal radiographic findings. Only few cases of fibrochondrogenesis are diagnosed before the termination of pregnancy. Received : 03-01-2012 Accepted : 28-01-2012 Key words: Antenatal diagnosis, fibrochorogenesis, platyspondyly, ultrasonography Published : 18-02-2012 INTRODUCTION (dumbbell shaped) and shortened ribs with pear-shaped vertebral bodies. We report a case of fibrochondrogenesis Fibrochondrogenesis is a genetically inherited form of with severe pear-shaped platyspondyly (flattened spine), osteochondrodysplasia that occurs in neonate. This lethal suspected on antenatal ultrasound examination. Only few variant results from the inheritance of an autosomal recessive cases of fibrochondrogenesis are diagnosed before the gene and causes abnormal development of cartilage and termination of pregnancy.[1] This case gives a comprehensive fibrous connective tissues.
    [Show full text]